CNCR Holdings

The Cancer Immunotherapy ETF

ETF Information as of 09/24/2018

ETF Holdings

COMPANY NAME ↓ TICKER ↓ CUSIP ↓ SHARES ↓ MARKET VALUE ↓ % OF NET ASSETS ↓
FATE THERAPEUTICS INC FATE 31189P102 194,700 $3,169,716.00 5.66%
MIRATI THERAPEUTICS INC MRTX 60468T105 47,581 $2,831,069.50 5.05%
MERCK & CO INC MRK 58933Y105 38,415 $2,719,013.70 4.85%
BRISTOL MYERS SQUIBB CO BMY 110122108 44,071 $2,714,332.89 4.84%
NOVARTIS A G NVS 66987V109 30,996 $2,643,648.84 4.72%
NEKTAR THERAPEUTICS NKTR 640268108 41,676 $2,536,818.12 4.53%
GILEAD SCIENCES INC GILD 375558103 33,258 $2,514,969.96 4.49%
XENCOR INC XNCR 98401F105 57,438 $2,479,024.08 4.42%
ASTRAZENECA PLC AZN 046353108 65,307 $2,471,869.95 4.41%
IOVANCE BIOTHERAPEUTICS INC IOVA 462260100 179,479 $2,360,148.85 4.21%
MACROGENICS INC MGNX 556099109 104,486 $2,296,602.28 4.10%
ADAPTIMMUNE THERAPEUTICS PLC SPONDS ADR ADAP 00653A107 192,251 $2,285,864.39 4.08%
BEIGENE LTD BGNE 07725L102 13,440 $2,231,846.40 3.98%
ZYMEWORKS INC ZYME 98985W102 142,306 $2,229,935.02 3.98%
CELLECTIS S A CLLS 15117K103 75,496 $2,208,258.00 3.94%
MORPHOSYS AG MOR 617760202 81,901 $2,195,765.81 3.92%
ATARA BIOTHERAPEUTICS INC ATRA 046513107 51,500 $2,096,050.00 3.74%
ARCUS BIOSCIENCES INC RCUS 03969F109 146,384 $1,971,792.48 3.52%
DYNAVAX TECHNOLOGIES CORP DVAX 268158201 148,018 $1,835,423.20 3.28%
FIVE PRIME THERAPEUTICS INC FPRX 33830X104 133,272 $1,839,153.60 3.28%
ADURO BIOTECH INC ADRO 00739L101 305,311 $1,816,600.45 3.24%
ZIOPHARM ONCOLOGY INC ZIOP 98973P101 550,559 $1,800,327.93 3.21%
CYTOMX THERAPEUTICS INC CTMX 23284F105 93,662 $1,733,683.62 3.09%
BLUEBIRD BIO INC BLUE 09609G100 11,935 $1,664,335.75 2.97%
SORRENTO THERAPEUTICS INC SRNE 83587F202 320,492 $1,362,091.00 2.43%
Cash & Other Cash&Other Cash&Other 19,358.18 $19,358.18 0.03%
*ETF holdings and allocations are subject to change at any time and should not be interpreted as an offer of these securities